193 related articles for article (PubMed ID: 12398577)
1. Sialorrhea - therapeutic drug options.
Tscheng DZ
Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
Sridharan K; Sivaramakrishnan G
J Clin Neurosci; 2018 May; 51():12-17. PubMed ID: 29475576
[TBL] [Abstract][Full Text] [Related]
3. Interventions for drooling in children with cerebral palsy.
Walshe M; Smith M; Pennington L
Cochrane Database Syst Rev; 2012 Nov; 11():CD008624. PubMed ID: 23152263
[TBL] [Abstract][Full Text] [Related]
4. Interventions for drooling in children with cerebral palsy.
Walshe M; Smith M; Pennington L
Cochrane Database Syst Rev; 2012 Feb; (2):CD008624. PubMed ID: 22336850
[TBL] [Abstract][Full Text] [Related]
5. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Chowdhury NA; Sewatsky ML; Kim H
Am J Phys Med Rehabil; 2017 Aug; 96(8):e151-e154. PubMed ID: 28081025
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of benztropine therapy for drooling.
Camp-Bruno JA; Winsberg BG; Green-Parsons AR; Abrams JP
Dev Med Child Neurol; 1989 Jun; 31(3):309-19. PubMed ID: 2666205
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
8. [Hypersalivation - inauguration of the S2k Guideline (AWMF) in short form].
Steffen A; Beutner D; Hakim S; Jost W; Kahl KG; Laskawi R; Lencer R; Mall V; Mehrhoff FW; Meyners T; Schönweiler R; Schröder S; Schröter-Morasch H; Schuster M; Steinlechner S; Winterhoff J; Zenk J; Guntinas-Lichius O;
Laryngorhinootologie; 2013 Aug; 92(8):515-22. PubMed ID: 23900923
[TBL] [Abstract][Full Text] [Related]
9. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
10. In brief: Glycopyrrolate oral solution for sialorrhea.
Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
[No Abstract] [Full Text] [Related]
11. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
13. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
Bachrach SJ; Walter RS; Trzcinski K
Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
[TBL] [Abstract][Full Text] [Related]
14. Controlling sialorrhoea: a review of available treatment options.
Potulska A; Friedman A
Expert Opin Pharmacother; 2005 Aug; 6(9):1551-4. PubMed ID: 16086642
[TBL] [Abstract][Full Text] [Related]
15. Acute sialadenitis secondary to submandibular calculi after botulinum neurotoxin injection for sialorrhea in a child with cerebral palsy.
Yuan M; Shelton J
Am J Phys Med Rehabil; 2011 Dec; 90(12):1064-7. PubMed ID: 22019967
[TBL] [Abstract][Full Text] [Related]
16. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
17. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
18. Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients.
Tassinari D; Poggi B; Fantini M; Tamburini E; Sartori S
Support Care Cancer; 2005 Jul; 13(7):559-61. PubMed ID: 15864657
[TBL] [Abstract][Full Text] [Related]
19. The management of drooling in adults with neurological conditions.
Squires N; Wills A; Rowson J
Curr Opin Otolaryngol Head Neck Surg; 2012 Jun; 20(3):171-6. PubMed ID: 22487791
[TBL] [Abstract][Full Text] [Related]
20. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
Egevad G; Petkova VY; Vilholm OJ
J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
